A short alpha-helical antimicrobial peptide with antibacterial selectivity

Song Yub Shin1, Kyung-Soo Hahm

  • 1Department of Bio-Materials, Graduate School and Research Center for Proteineous Materials, Chosun University, Gwangju 501-759, Korea. syshin@chosun.ac.kr

Biotechnology Letters
|June 16, 2004
PubMed

Insights

A novel peptide, K6L5WP, shows potent antibacterial activity against Gram-positive and Gram-negative bacteria without causing hemolysis. Its selective interaction with bacterial membranes suggests potential as a new antimicrobial agent.

Area of Science:

  • Biochemistry
  • Microbiology
  • Peptide Design

Background:

  • Antimicrobial peptides (AMPs) are crucial in innate immunity.
  • Developing AMPs with high efficacy and low toxicity is a significant challenge.
  • Hemolytic activity often limits the therapeutic potential of AMPs.

Purpose of the Study:

  • To design and evaluate a novel alpha-helical peptide (K6L5WP) for potent and selective antimicrobial activity.
  • To investigate the mechanism underlying the peptide's bacterial selectivity.
  • To assess the potential of K6L5WP as a candidate for antimicrobial drug development.

Main Methods:

  • Peptide synthesis and characterization.
  • Determination of antibacterial activity using minimum inhibitory concentration (MIC) assays.
  • Evaluation of hemolytic activity against red blood cells.
  • Tryptophan fluorescence spectroscopy to study peptide-membrane interactions.

Main Results:

  • K6L5WP demonstrated strong antibacterial activity (MIC: 2–4 µM) against both Gram-positive and Gram-negative bacteria.
  • K6L5WP exhibited no hemolytic activity, unlike its precursor peptide.
  • Tryptophan fluorescence studies revealed selective binding of K6L5WP to negatively charged bacterial phospholipids.
  • The central Pro6 residue was identified as critical for bacterial selectivity.

Conclusions:

  • K6L5WP possesses potent and selective antibacterial properties.
  • The peptide's mechanism involves preferential interaction with bacterial cell membranes.
  • K6L5WP represents a promising lead compound for developing novel antimicrobial agents with reduced host toxicity.

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...